INFU Putting in a Bottom?Is INFU putting in a bottom? It sure looks like a base is building over the last week. It looks like the short squeeze is coming in. Volume is low but this one is going on the watchlist.
If the volume comes in and the stock continues to climb, it could close the gaps in the targets all listed in grey. This stock is sitting at $5.83 and the analyst have it priced at $14.13. With time that is a great increase in a beaten down stock. The RSI is oversold at 35.18. This stock moves at $0.35 a day so it'll take some time to get back to the full valuation of $14.13. Stop loss at $5.73.
This company has also been raising it's revenue and margin each year since 2022.
Let's see where this one goes. As always, do your own research and due diligence. Not investment nor trading advice.
INFU trade ideas
INFU Announces Master Service AgreementInfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
Infusystem making new highs after earnings beatINFU is making new highs after another earnings surprise. It's up >30% after testing the 150d MA and is up 192% from March lows. The gains since the earnings date results in a bigger 10d ATR (x2.7) stop at 12.25%. So a smaller position of R8.16 is required to control risk.
Stop Loss: 12.25% (13.39)
Position Size: R8.16
$INFU Forming 3 Months #Rectangle #Consolidation #ChartPatternAMEX:INFU been consolidating for 3 months forming a well defined 3 months rectangle chart pattern. the chart pattern is forming right below ATH at $13.25. Once cleared, the breakout should make a run to price pattern target identified on the chart.
$INFU:NYSE - INFUSYSTEM HOLDINGS - Breakout Ahead?INFU has been having a nice steady run - up over 130% over the last 12 months, but momentum has been falling forming a bit of a hill top. The Bollinger Bands have been compressing and yesterday we saw an attempt at a breakout with quite big volume. It didn't succeed but could be worth a watch over the next day or so to see if it will indeed run. It did this once before in October with a very similar candle which saw the price fall away before resuming its run. Worth keeping an eye on it.
InfuSystem Holdings, Inc. engages in the provision of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites. The firm also provides its products and services to hospitals, oncology practices and facilities and other alternate site health care providers. The company was founded in August 2005 and headquartered in Madison Heights, MI.